Mostafa Kamal, CEO, Magellan Rx Management at MAGELLAN HEALTH INC (MGLN), sold 5,586 shares at $79.69 ($445K) on 2020-12-09, disclosed to the SEC on 2020-12-11.
Open-market sale of $445k MGLN by CEO, Magellan Rx Management. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.69 | 2,793 | $223K | 50.0% |
| 2 | $79.69 | 2,793 | $223K | 50.0% |
| Total | $79.69 avg | 5,586 | $445K | 100% |
| Filing → |
| MGLN | SELL | 2020-11-06 | $1.1M | — | Filing → |
| MGLN | SELL | 2020-10-20 | $15K | — | Filing → |
| MGLN | SELL | 2019-12-11 | $2.6M | — | Filing → |